PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 3, 2025Future Journal of Pharmaceutical Sciences3 citationsOpen Access

A systematic review on the dynamic interplay between the immune system and gut microbiome in inflammatory bowel disease patients

View Full Paper
DADanah AlmusallamSASamiah Alhabardi

Key Points

  • Dysregulated immune responses with increased pro-inflammatory cytokines are common in IBD patients.
  • The review identifies reduced microbial diversity and increased pathogenic strains in inflammatory bowel disease.
  • Short-chain fatty acids, crucial for gut health, are decreased in patients with inflammatory bowel disease.
  • Understanding the mutual influence of the immune system and gut microbiota could lead to better treatment strategies.

Abstract

Abstract Background Understanding how a disease develops and the factors that influence any deviation from the balance created by the body is critical in tailoring appropriate treatment for each patient. Existing literature discusses each factor separately, and simply touches on the interaction by recognizing its existence. The objective of this study is to delve in to the relationship between the immune system and the gut microbiota, and how they in turn affect each other and ultimately lead to a diseased state. Methods To locate relevant published research, a comprehensive search of electronic databases was performed. Eligible studies were chosen based on predetermined inclusion criteria, which included original research publications exploring the link between the immune system and gut microbiome in IBD patients. Data extraction and quality evaluation followed the PRISMA recommendations. The included studies used a variety of techniques, including observational cohort studies, case–control studies, and experimental research. Results Changes in systems from homeostatic function include a dysregulated immune response with heightened pro-inflammatory cytokines, disrupted gut barrier permeability due to increased epithelial permeability and disrupted tight junctions, reduced microbial diversity with elevated levels of pathogenic strains and bacteriophages. Short-chain fatty acids which promote gut barrier integrity and possess anti-inflammatory effects are reduced in patients with IBD. Discussion Key findings from the literature review emphasize the role of gut microbiota in immunological responses in IBD, as well as the reciprocal impact of immune dysregulation on microbiome composition. Further research is needed to understand the molecular interaction between the immune system and the gut microbiota (Caron et al. in J Crohns Colitis 18:ii3–ii15, 2024. https://doi.org/10.1093/ECCO-JCC/JJAE082 ).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Almusallam et al. (2025) studied this question.

synapsesocial.com/papers/68e040f3a99c246f578b393chttps://doi.org/10.1186/s43094-025-00891-7
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021 · 104,483 citations
  2. 2Cytokines, Inflammation, and Pain2007 · 2,995 citations
  3. 3Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease2002 · 155 citations
  4. 4V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells2002 · 59 citations
  5. 5Divergent Roles of Interferon-γ and Innate Lymphoid Cells in Innate and Adaptive Immune Cell-Mediated Intestinal Inflammation2018 · 39 citations